Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis
2009 ◽
Vol 215
(1-2)
◽
pp. 125-128
◽
Keyword(s):
2006 ◽
Vol 103
(15)
◽
pp. 5941-5946
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 276
(1-2)
◽
pp. 180-186
◽
Keyword(s):
2017 ◽
Vol 88
(5)
◽
pp. e1.51-e1
Keyword(s):
2018 ◽
Vol 09
(07)
◽
pp. 541-565
2016 ◽
Vol 11
(5)
◽
pp. 733
◽
Keyword(s):
Keyword(s):